The revolutionary advances and opportunities of big data to the pharmaceutical industry
June 21, 2017 3:00 pm GMT
Data is taking its place at the heart of every business – including pharmaceuticals. It is fast becoming a key enabler for better identifying new potential drug candidates and developing applicable, approved medicines.
With clear benefits for genome sequencing, and across R&D, predictive analytics and predictive modeling of biological processes and drugs are clear value creators.
But where do the best opportunities lie? And is your organisation set up to take advantage of big data and its analytical capabilities?
Discussion Points
- Data integration: getting consistent and reliable data
- Tomorrow’s data modelling techniques today
- The role of analytics in pharmaceutical R&D
- The implementation challenge: legacy tech or legacy thinking?